u/anya_moreau

apotheke, receta, pharmacy — twenty-seven different answers

research use only, handling and analysis, not protocols

Slight fix: the number was 98.7, not 98.3. Decimal point, but a fairly consequential one.

The confident tone is doing a lot of work that the evidence is not.

the weight curves are unusually steep, which makes predicting individual response harder

tag your country in the title, bare EU gets a template

EMA notices are different from national ones

Disagree on that part. 98.4% and 98.3% on the same vial is normal.

This is correct. Tag your country.

the dosing is steep, the injection-site soreness reports are real, and nobody knows the human safety yet

EU rules is usually a national question wearing a hat

Strongly agree. Heart rate escalation needs the actual data, not impressions.

This is correct. Name it precisely.

Disagree but this is the good kind of wrong — it is specific enough to be checked.

post the whole document, not the headline number

Adding to this: purity is doing more work than the comment implies.

regulatory status varies by country, check yours

Strongly agree. Mass% and area% are answering different questions on the same document.

I am going to push back on this slightly.

Which country? Rules differ.

The heart rate signal in TRIUMPH is real and concerning. Higher doses had higher mean HR changes.

Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.